Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio
08 nov. 2018 07h00 HE
|
Vectura Group plc
Vectura Group announces global agreement with Hikma to develop generic versions of GSK’s Ellipta® portfolio Upfront payment of US$15mUp to US$80m of development milestone payments Mid teen...